FERIFER

[ Perfumery, cosmetics, deodorants for personal use; soaps for personal use ]

Pharmaceuticals for human health in the treatment of anemia and assisting energy metabolism; systemic anti-infectives, namely, antibacterial and antifungal pharmaceuticals; musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, anti-Parkinson preparations; pharmaceuticals for the treatment of respiratory diseases and asthma; dermatological pharmaceutical products; pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; anti-diabetic pharmaceuticals; pharmaceuticals for the treatment of bone diseases and joint diseases; pharmaceuticals for the treatment of viral and infectious diseases; pharmaceuticals for use as antineoplastic agents; pharmaceuticals for the treatment of immune system related diseases and disorders; pharmaceuticals for the treatment of kidney diseases; pharmaceuticals for ophthalmological use; chemical preparations for medical purposes, namely, vitamins and mineral supplements to support the growth of children, vitamins and dietary supplements to support arousing the appetite